Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Pozas

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Cancers|June 18, 2020
BRAF Mutated Colorectal Cancer: New Treatment ApproachesJavier Molina-Cerrillo, María San Román, Javier Pozas, et al.
European Journal of Cancer (Oxford, England : 1990)|January 14, 2025
Ossifying fibromyxoid tumours: A case seriesJavier Pozas, Khin Thway, Daniel Lindsay, et al.
Cancer Treatment Reviews|March 6, 2022
Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategiesMaría San Román-Gil, Javier Pozas, Diana Rosero-Rodríguez, et al.
Cancers|December 10, 2021
Molecular Mechanisms of Resistance to Immunotherapy and Antiangiogenic Treatments in Clear Cell Renal Cell CarcinomaPablo Álvarez Ballesteros, Jesús Chamorro, María San Román-Gil, et al.
International Journal of Molecular Sciences|November 17, 2020
Tyrosine Kinase Receptors in OncologyJorge Esteban-Villarrubia, Juan José Soto-Castillo, Javier Pozas, et al.
International Journal of Molecular Sciences|January 16, 2021
Novel Tyrosine Kinase Targets in Urothelial CarcinomaJavier Torres-Jiménez, Víctor Albarrán-Fernández, Javier Pozas, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 25, 2025
A novel risk score after neoadjuvant imatinib predicts relapse-free survival in patients with gastrointestinal stromal tumours (GIST)Javier Pozas, Daniel Lindsay, Alanna Wall, et al.
Frontiers in Oncology|May 22, 2023
Maintained complete response to talazoparib in a <i>BRCA-2</i> mutated metastatic luminal breast cancer: case report and review of literatureVíctor Albarrán, Jesús Chamorro, Javier Pozas, et al.
International Journal of Molecular Sciences|October 27, 2022
Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug ConjugatesVíctor Albarrán, Diana Isabel Rosero, Jesús Chamorro, et al.
Cancers|May 16, 2023
Current Landscape of Immunotherapy for Advanced SarcomaVíctor Albarrán, María Luisa Villamayor, Javier Pozas, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cancers|June 18, 2020
BRAF Mutated Colorectal Cancer: New Treatment ApproachesJavier Molina-Cerrillo, María San Román, Javier Pozas, et al.
European Journal of Cancer (Oxford, England : 1990)|January 14, 2025
Ossifying fibromyxoid tumours: A case seriesJavier Pozas, Khin Thway, Daniel Lindsay, et al.
Cancer Treatment Reviews|March 6, 2022
Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategiesMaría San Román-Gil, Javier Pozas, Diana Rosero-Rodríguez, et al.
Cancers|December 10, 2021
Molecular Mechanisms of Resistance to Immunotherapy and Antiangiogenic Treatments in Clear Cell Renal Cell CarcinomaPablo Álvarez Ballesteros, Jesús Chamorro, María San Román-Gil, et al.
International Journal of Molecular Sciences|November 17, 2020
Tyrosine Kinase Receptors in OncologyJorge Esteban-Villarrubia, Juan José Soto-Castillo, Javier Pozas, et al.
International Journal of Molecular Sciences|January 16, 2021
Novel Tyrosine Kinase Targets in Urothelial CarcinomaJavier Torres-Jiménez, Víctor Albarrán-Fernández, Javier Pozas, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 25, 2025
A novel risk score after neoadjuvant imatinib predicts relapse-free survival in patients with gastrointestinal stromal tumours (GIST)Javier Pozas, Daniel Lindsay, Alanna Wall, et al.
Frontiers in Oncology|May 22, 2023
Maintained complete response to talazoparib in a <i>BRCA-2</i> mutated metastatic luminal breast cancer: case report and review of literatureVíctor Albarrán, Jesús Chamorro, Javier Pozas, et al.
International Journal of Molecular Sciences|October 27, 2022
Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug ConjugatesVíctor Albarrán, Diana Isabel Rosero, Jesús Chamorro, et al.
Cancers|May 16, 2023
Current Landscape of Immunotherapy for Advanced SarcomaVíctor Albarrán, María Luisa Villamayor, Javier Pozas, et al.
Pageof 3